Form 4 for BHC Bausch Health Companies Inc.
Accepted 2022-03-07 00:00:00 ET · period of report 2022-03-03 · accession 0001127602-22-008498 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-07 | 2022-03-03 | BHC | Spurr Robert | U.S. Pres-Pharma Business | F - Tax | $23.61 | -4,074 | 96.9K | -4% | -$96.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, No Par Value | 2022-03-03 | F | D | 4,074 | $23.61 | 96,947 | D | — | — | (F1) This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. |